Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human gonadotrophins.

L Nilsson, L Hamberger

    Bailliere'S Clinical Obstetrics and Gynaecology
    |September 1, 1990
    PubMed
    Summary
    This summary is machine-generated.

    Exogenous gonadotrophic hormone therapy for infertility is safe, with no increased risks of abnormalities or cancer in children. Careful management is needed, especially for women with regular cycles, to prevent adverse effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Avoidance of multiple pregnancy by use of single embryo transfer.

    Minerva ginecologica·2005
    Same author

    Internalization of cellular fragments in a human embryo: time-lapse recordings.

    Reproductive biomedicine online·2002
    Same author

    Preimplantation genetic diagnosis (PGD): the Gothenburg experience.

    Acta obstetricia et gynecologica Scandinavica·2001
    Same author

    The early genetic diagnosis from a clinical perspective.

    Acta obstetricia et gynecologica Scandinavica·2000
    Same author

    Ultrastructure of human blastocyst-endometrial interactions in vitro.

    Journal of reproduction and fertility·2000
    Same author

    The position of the metaphase II spindle cannot be predicted by the location of the first polar body in the human oocyte.

    Human reproduction (Oxford, England)·2000
    Same journal

    The use of gonadotrophin-releasing hormone antagonists in polycystic ovarian disease.

    Bailliere's clinical obstetrics and gynaecology·2000
    Same journal

    Use of luteinizing hormone releasing hormone agonists in polycystic ovary syndrome.

    Bailliere's clinical obstetrics and gynaecology·2000
    Same journal

    Epithelial ovarian cancer, infertility and induction of ovulation: possible pathogenesis and updated concepts.

    Bailliere's clinical obstetrics and gynaecology·2000
    Same journal

    Complications of ovarian stimulation.

    Bailliere's clinical obstetrics and gynaecology·2000
    Same journal

    Adverse effects of luteinizing hormone on fertility: fact or fantasy.

    Bailliere's clinical obstetrics and gynaecology·2000
    Same journal

    Surgical management of polycystic ovarian syndrome.

    Bailliere's clinical obstetrics and gynaecology·2000
    See all related articles

    Area of Science:

    • Reproductive Endocrinology
    • Medical Safety
    • Infertility Treatment

    Background:

    • Exogenous gonadotrophic hormones have been used for over 30 years to treat female infertility.
    • Previous studies indicate no increased incidence of abnormalities in children born after such treatments.
    • Long-term follow-up has not revealed an increased risk of malignant diseases in patients undergoing gonadotrophic stimulation.

    Purpose of the Study:

    • To evaluate the safety and efficacy of exogenous gonadotrophic hormone treatment for female infertility.
    • To discuss the management of different patient categories, including WHO group I and group II infertility.
    • To highlight the need for careful drug combinations and regimens to mitigate adverse effects.

    Main Methods:

    • Review of existing literature and clinical data on gonadotrophic hormone therapy for infertility.

    Related Experiment Videos

  • Analysis of outcomes in children born after treatment, including genetic and reproductive assessments.
  • Evaluation of maternal health outcomes, focusing on the incidence of malignant diseases.

    • Main Results:

    • Treatment with exogenous gonadotrophic hormones is considered safe, with no observed increase in abnormalities in offspring.
    • Reproductive ability of children born after treatment appears normal.
    • No increased incidence of breast, ovarian, or endometrial cancer has been reported in treated women.

    Conclusions:

    • Exogenous gonadotrophic hormone therapy is a safe and effective treatment for specific types of female infertility.
    • Careful consideration of patient-specific factors and combination therapies is crucial, particularly for women with regular cycles (WHO group II).
    • Management strategies should account for endogenous gonadotrophins to optimize outcomes and minimize risks.